Radiological confirmation of brain death is required when the preconditions for clinical brain death testing cannot be met. The objective of these tests is to demonstrate an absence of blood flow above the foramen magnum. The college love to ask candidates about the preconditions of clinical testing, as well as the specific radiological modalities available. Again, the ANZIC statement on Brain Death and Organ Donation is my primary resource for this summary. At the time of writing, the recent edition is Version 4.1 (2021).
Previous SAQs involving the radiological diagnosis of brain death include the following:
Broadly speaking, these are almost the same as the contraindicatiosn to clinical testing.
The indications for choosing a radionuclide scan, rather than a DSA, may be as follows:
ANZICS Death and Organ Donation Committee, THE ANZICS STATEMENT ON DEATH AND ORGAN DONATION Edition 4.1 (2021)
Wieler, H., et al. "Tc-99m HMPAO Cerebral Scintigraphy A Reliable, Noninvaslve Method for Determination of Brain Death." Clinical nuclear medicine18.2 (1993): 104-109.
Donohoe, Kevin J., et al. "SNM practice guideline for brain death scintigraphy 2.0." Journal of nuclear medicine technology 40.3 (2012): 198-203.
Munari, Marina, et al. "Confirmatory tests in the diagnosis of brain death: comparison between SPECT and contrast angiography." Critical care medicine33.9 (2005): 2068-2073.
Joffe, Ari R., Laurance Lequier, and Dominic Cave. "Specificity of radionuclide brain blood flow testing in brain death: case report and review." Journal of intensive care medicine 25.1 (2010): 53-64.
Heran, Manraj KS, Navraj S. Heran, and Sam D. Shemie. "A review of ancillary tests in evaluating brain death." The Canadian Journal of Neurological Sciences35.4 (2008): 409-419.
Taylor, Tim, et al. "Computed tomography (CT) angiography for confirmation of the clinical diagnosis of brain death." The Cochrane Library (2014).